|
GPR180 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.04699623707461E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.78180001256345E-09 |
| Normal-vs-Stage2 |
6.19720000000212E-05 |
| Normal-vs-Stage3 |
3.45340001040029E-09 |
| Normal-vs-Stage4 |
1.52669998865207E-09 |
| Stage1-vs-Stage2 |
8.567600E-01 |
| Stage1-vs-Stage3 |
4.253200E-01 |
| Stage1-vs-Stage4 |
6.851600E-02 |
| Stage2-vs-Stage3 |
4.934200E-01 |
| Stage2-vs-Stage4 |
1.822590E-01 |
| Stage3-vs-Stage4 |
3.571800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.98669969364573E-11 |
| Normal-vs-AfricanAmerican |
9.645700E-04 |
| Normal-vs-Asian |
4.52439999998333E-06 |
| Caucasian-vs-AfricanAmerican |
3.561400E-01 |
| Caucasian-vs-Asian |
6.100200E-01 |
| AfricanAmerican-vs-Asian |
6.409600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.35320005095952E-09 |
| Normal-vs-Female |
2.84519963145158E-10 |
| Male-vs-Female |
3.722800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.11599999533752E-08 |
| Normal-vs-Age(41-60Yrs) |
9.49680001305353E-10 |
| Normal-vs-Age(61-80Yrs) |
4.87050000330669E-09 |
| Normal-vs-Age(81-100Yrs) |
5.177900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.764400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.133600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.601400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.938600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.294200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.806600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.403400E-01 |
| Classical-VS-Follicular |
3.545400E-01 |
| Classical-VS-Other |
4.337000E-01 |
| Classical-VS-Normal |
2.44170017538181E-10 |
| Tall-VS-Follicular |
8.310100E-02 |
| Tall-VS-Other |
8.452600E-01 |
| Tall-VS-Normal |
5.16099999958719E-07 |
| Follicular-VS-Other |
3.597000E-01 |
| Follicular-VS-Normal |
8.32570000000032E-05 |
| Other-VS-Normal |
2.757700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.89499979544416E-10 |
| Normal-vs-N1 |
4.68530003683298E-09 |
| N0-vs-N1 |
3.132600E-01 |
|
|
